Jazz Pharmaceuticals to Participate in the 2025 Wells Fargo Healthcare Conference
Jazz Pharmaceuticals (NASDAQ:JAZZ) announced its participation in the upcoming 2025 Wells Fargo Healthcare Conference. Company management will conduct a fireside chat on September 3, 2025, at 6:30 a.m. PDT.
The presentation will be accessible through a live audio webcast on the company's investor relations website, with replays available for 30 days. Jazz Pharmaceuticals is a global biopharma company focused on developing life-changing medicines for sleep disorders, epilepsy, and cancer treatments.
Jazz Pharmaceuticals (NASDAQ:JAZZ) ha annunciato la sua partecipazione al Wells Fargo Healthcare Conference 2025. La direzione dell'azienda terr脿 un fireside chat il 3 settembre 2025 alle 6:30 PDT.
La presentazione sar脿 trasmessa in diretta audio via webcast sul sito investor relations della societ脿, con le registrazioni disponibili per 30 giorni. Jazz Pharmaceuticals 猫 un'azienda biofarmaceutica globale dedicata allo sviluppo di terapie che migliorano la vita per i disturbi del sonno, l'epilessia e i trattamenti oncologici.
Jazz Pharmaceuticals (NASDAQ:JAZZ) anunci贸 su participaci贸n en la Wells Fargo Healthcare Conference 2025. La direcci贸n de la compa帽铆a ofrecer谩 un fireside chat el 3 de septiembre de 2025 a las 6:30 a.m. PDT.
La presentaci贸n se podr谩 seguir mediante un webcast de audio en directo en la web de relaciones con inversores de la empresa, y las repeticiones estar谩n disponibles durante 30 d铆as. Jazz Pharmaceuticals es una empresa biofarmac茅utica global centrada en desarrollar medicamentos que cambian la vida para trastornos del sue帽o, epilepsia y tratamientos contra el c谩ncer.
Jazz Pharmaceuticals (NASDAQ:JAZZ)電� 雼り皜鞓る姅 2025 Wells Fargo Healthcare Conference鞐� 彀戈皜頃滊嫟瓿� 氚滍憸頄堨姷雼堧嫟. 須岇偓 瓴届榿歆勳潃 2025雲� 9鞗� 3鞚� 鞓れ爠 6:30 PDT鞐� 韺岇澊鞏挫偓鞚措摐 毂勴寘鞚� 歆勴枆頃╇媹雼�.
氚滍憸電� 須岇偓 韴瀽鞛愱磤瓿� 鞗轨偓鞚错姼鞐愳劀 霛检澊敫� 鞓る敂鞓� 鞗轨簮鞀ろ姼搿� 鞁滌箔頃� 靾� 鞛堨溂氅�, 雼れ嫓氤搓赴電� 30鞚缄皠 鞝滉车霅╇媹雼�. Jazz Pharmaceuticals電� 靾橂┐鞛レ暊, 臧勳 氚� 鞎� 旃橂毳� 鞙勴暅 靷鹅潉 氚旉靖電� 鞚橃暯頀� 臧滊皽鞐� 欤茧牓頃橂姅 旮�搿滊矊 氚旍澊鞓れ牅鞎� 須岇偓鞛呺媹雼�.
Jazz Pharmaceuticals (NASDAQ:JAZZ) a annonc茅 sa participation 脿 la Wells Fargo Healthcare Conference 2025. La direction de la soci茅t茅 tiendra un fireside chat le 3 septembre 2025 脿 6h30 PDT.
La pr茅sentation sera accessible via un webcast audio en direct sur le site relations investisseurs de l'entreprise, avec des rediffusions disponibles pendant 30 jours. Jazz Pharmaceuticals est une soci茅t茅 biopharmaceutique mondiale d茅di茅e au d茅veloppement de m茅dicaments qui changent la vie pour les troubles du sommeil, l'茅pilepsie et les traitements contre le cancer.
Jazz Pharmaceuticals (NASDAQ:JAZZ) hat seine Teilnahme an der Wells Fargo Healthcare Conference 2025 angek眉ndigt. Das Management des Unternehmens wird am 3. September 2025 um 6:30 Uhr PDT ein Fireside-Chat durchf眉hren.
Die Pr盲sentation wird 眉ber einen Live-Audio-Webcast auf der Investor-Relations-Webseite des Unternehmens verf眉gbar sein; Wiedergaben sind f眉r 30 Tage abrufbar. Jazz Pharmaceuticals ist ein globales Biopharma-Unternehmen, das sich auf die Entwicklung lebensver盲ndernder Medikamente f眉r Schlafst枚rungen, Epilepsie und Krebstherapien konzentriert.
- None.
- None.
An audio webcast of the fireside chat will be available via the Investors section of the Jazz Pharmaceuticals website at . A replay of the webcasts will be archived on the website for 30 days.
Audio webcasts of the presentations will be available via the Investors section of the Jazz Pharmaceuticals website at . A replay of the webcasts will be archived on the website for 30 days.
About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases 鈥� often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines, including leading therapies for sleep disorders and epilepsy, and a growing portfolio of cancer treatments. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics in oncology and neuroscience. Jazz is headquartered in
Contacts:
Investors:
Jack Spinks
Executive Director, Investor Relations
Jazz Pharmaceuticals plc
[email protected]
Media:
Kristin Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc
[email protected]
View original content to download multimedia:
SOURCE Jazz Pharmaceuticals plc
FAQ
When is Jazz Pharmaceuticals (JAZZ) presenting at the Wells Fargo Healthcare Conference 2025?
How can investors access Jazz Pharmaceuticals' Wells Fargo conference presentation?
What are Jazz Pharmaceuticals' main therapeutic areas?
Where is Jazz Pharmaceuticals headquartered?
